Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2008
01/24/2008US20080020393 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease
01/24/2008US20080020392 Motion resolved molecular sequencing
01/24/2008US20080020391 Lateral flow methods and devices for detection of nucleic acid binding proteins
01/24/2008US20080020390 detecting specific single nucleotide polymorphisms (SNPs) in the genome of human fetus, and their association with acute coronary events and/or variability in the responsiveness to statin treatment (including preventive treatment) between different individuals; assessing for risk of heart disease
01/24/2008US20080020389 Methods of detecting a target nucleic acid
01/24/2008US20080020388 identifying a patient suffering from active relapsing remitting multiple sclerosis; comparing amount of XIAP and HIAP-2 gene expression levels in peripheral blood mononuclear (PBMN) cells with control
01/24/2008US20080020387 Biomarker-optimized adhd treatment
01/24/2008US20080020386 Methods and apparatus for genotyping
01/24/2008US20080020385 Use Of A Genetic Modification In The Human Gnaq Gene For Predicting Risk Of Disease, The Course Of Disease, And Reaction To Treatments
01/24/2008US20080020384 for stably measuring an enzyme activity of various luciferases using coelenterazine (Renilla luciferin) or an analog thereof as a substrate at room temperature over a long time
01/24/2008US20080020383 Haplotype Markers And Methods Of Using The Same To Determine Response To Treatment
01/24/2008US20080020382 Biological Microbeads for Various Flow Cytometric Applications
01/24/2008US20080020381 Methods, compositions, and systems for the identification of species-specific or developmental stage-specific insecticides
01/24/2008US20080020380 For detecting nucleic acids; for quicker and cheaper methods of identifying nucleic acids
01/24/2008US20080020379 Diagnosis and prognosis of infectious diseases clinical phenotypes and other physiologic states using host gene expression biomarkers in blood
01/24/2008US20080020378 Fluorescent base analogues' usage in the characterization of nucleic acid molecules and their interactions
01/24/2008US20080020377 Peptide-Based Method for Monitorting Gene Expression in a Host Cell
01/24/2008US20080020376 Enriched Cdna Expression Libraries and Methods of Making and Using Same
01/24/2008US20080020375 Method Of Adjudicating On Prostate Cancer
01/24/2008US20080020374 detecting and/or quantifying molecules expressing selected epitope using antibodies linked to nucleic acid templates suitable for use in RNA amplification application whereby the amplification product is stained with a fluorescent dye in order to detect and quantify ; profiling proteins in a cell lysate
01/24/2008US20080020373 Composition for Detecting the Response of Rectal Adenocarcinomas to Radiochemotherapy
01/24/2008US20080020372 Methods for Detecting and Treating Cancer
01/24/2008US20080020371 Reverse Genetics System
01/24/2008US20080020370 Heteroduplex tracking assay
01/24/2008US20080020369 Neurotoxicity methods process
01/24/2008US20080020368 Method and apparatus for exposing cells to different concentrations of analytes or drugs
01/24/2008US20080019988 Targeting of genetic vaccine vectors
01/24/2008US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
01/24/2008US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
01/24/2008US20080019979 HERV-K Antigens, Antibodies, and Methods
01/24/2008US20080019973 Methods for Treating Ocular Inflammation by Neutralizing Cxcl10 Activity
01/24/2008US20080019971 36P6D5: secreted tumor antigen
01/24/2008US20080019961 Hedgehog signaling pathway antagonist cancer treatment
01/24/2008US20080019958 Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof
01/24/2008US20080019952 Novel Method for the Preparation of Embryoid Bodies (Ebs) and Uses Thereof
01/24/2008US20080019950 Novel hepatocyte-like cells and hepatoblast-like cells derived from hBS cells
01/24/2008US20080019949 Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells
01/24/2008US20080019920 Neurotransmitter Sensors and Methods of Using the Same
01/24/2008US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis
01/24/2008US20080019914 Pesticidally Active Proteins and Polynucleotides Obtainable from Paenibacillus Species
01/24/2008US20080019911 Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4
01/24/2008US20080019910 Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease Inhibitors
01/24/2008US20080019909 Modulation of Programmed Necrosis
01/24/2008US20080019872 Circuits for the Control of Output Current in an Electronic Device for Performing Active Biological Operations
01/24/2008US20080018898 Minimizing Effects of Dye Crosstalk
01/24/2008US20080017522 Integrated Lancing and Measurement Device
01/24/2008DE10259677B4 Sonden zum Nachweis von Nukleinsäuren, insbesondere zum Nachweis pathogener Keime in Lebensmitteln Probes for the detection of nucleic acids, especially for the detection of pathogenic bacteria in food
01/24/2008DE102006032610A1 Verfahren zur parallelen Isolierung viraler Nukleinsäuren A method for parallel isolation of viral nucleic acids
01/24/2008CA2658694A1 Method for the detection of egfr mutations in blood samples
01/24/2008CA2658645A1 Method for identifying novel genes
01/24/2008CA2658596A1 Method for screening an enhancer or a masker of salty taste
01/24/2008CA2658403A1 Microfluidic device for crystallization and chrystallographic analysis of molecules
01/24/2008CA2658336A1 Detection or isolation of target molecules using a microchannel apparatus
01/24/2008CA2658319A1 Methods and compositions for the diagnosis and treatment of cancer
01/24/2008CA2658305A1 Transcription infidelity, detection and uses thereof
01/24/2008CA2658267A1 Sdf-1 binding nucleic acids
01/24/2008CA2658071A1 Specialized oligonucleotides and their use in nucleic acid amplification and detection
01/24/2008CA2657616A1 Prognostic method
01/24/2008CA2657493A1 Prognostic method
01/24/2008CA2657478A1 Diagnostic method
01/24/2008CA2656908A1 Modulators of lanosterol synthetase in the treatment of acne or of hyperseborrhoea
01/24/2008CA2656891A1 Modulators of elovl5 in the treatment of acne or of hyperseborrhoea
01/24/2008CA2656866A1 A reagent for digestion of hemoglobin
01/24/2008CA2656844A1 Modulators of scarb-1 in the treatment of acne or of hyperseborrhoea
01/24/2008CA2656842A1 Modulators of udp-glucose ceramide glucosyltransferase in the treatment of acne or of hyperkeratinization
01/24/2008CA2656841A1 Modulators of hsd17b7 in the treatment of acne or of hyperseborrhoea
01/24/2008CA2656839A1 Modulators of sc4mol in the treatment of acne or of hyperseborrhoea
01/24/2008CA2656838A1 Modulators of the abcd3 transporter in the treatment of acne or of hyperseborrhoea
01/24/2008CA2656807A1 Early detection and prognosis of colon cancers
01/24/2008CA2616559A1 Devices and methods for the selection of agents with efficacy against biofilm
01/23/2008EP1881327A2 Diagnosis and treatment of malignant neoplasms
01/23/2008EP1881081A1 Combinations of markers for increased accuracy of diagnosis of rheumatoid arthritis
01/23/2008EP1881080A1 Toll like receptor 4 dysfunction and the biological applications thereof
01/23/2008EP1881079A1 Method for the detection of EGFR mutations in blood samples
01/23/2008EP1881070A2 Human cytokine as ligand of the zalpha receptor and uses thereof
01/23/2008EP1881068A1 Primer and probe for use in detection of mycobacterium kansasii and method for detection of mycobacterium kansasii using the same
01/23/2008EP1881065A1 DINO polypetide
01/23/2008EP1881061A1 Cell observation apparatus, method of cell observation and cell observation program
01/23/2008EP1881007A1 LLR-J24 related proteins
01/23/2008EP1880766A1 Analysis system based on porous material for highly-parallel single cell detection
01/23/2008EP1880759A2 Post-Synthesis Processing System for Supported Oligonucleotides, and Method
01/23/2008EP1880214A1 Method for identifying modulators of noah10 useful for treating alzheimer's disease
01/23/2008EP1880206A2 Multiplex capture of nucleic acids
01/23/2008EP1880203A2 Baselining amplification data
01/23/2008EP1880027A2 Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster
01/23/2008EP1880026A1 Genetic polymorphisms associated with myocardial infarction and uses thereof
01/23/2008EP1880025A2 Multiplex branched-chain dna assays
01/23/2008EP1880024A2 Polymorphic ghsr nucleic acids and uses thereof
01/23/2008EP1880023A1 Method for quantitative analysis of methyl cytosine in dna and uses thereof
01/23/2008EP1880022A1 Nucleic acid-binding chips for detecting glucose deficiency conditions within the scope of bioprocess control
01/23/2008EP1880021A2 Oligonucleotide probe/primer compositions and methods for polynucleotide detection
01/23/2008EP1880020A2 Cellular biomarker antioxidant assay and uses thereof
01/23/2008EP1880019A1 Self-assembled nucleic acid nanoarrays and uses therefor
01/23/2008EP1880018A1 A method for detecting c. albicans
01/23/2008EP1880017A1 Process for producing ligands, ligands and test kit
01/23/2008EP1880016A2 Enhancing a luminescent signal
01/23/2008EP1880015A2 Method of identifying cd4+ t cell antigens
01/23/2008EP1880011A2 Transgenic expression cartridges for expressing nucleic acids in the flower tissue of plants
01/23/2008EP1879906A2 Reversible nucleotide terminators and uses thereof
01/23/2008EP1791973A4 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia